-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – VX-708 in Pain
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.VX-708 in Pain Drug Details:VX-708 is under development for the treatment of acute pain. The drug...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ZL-1218 in Solid Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.ZL-1218 in Solid TumorDrug Details:ZL-1218 is under development for the treatment of solid tumor. The drug...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Arsenic Trioxide in Mantle Cell Lymphoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Arsenic Trioxide in Mantle Cell Lymphoma Drug Details: Arsenic trioxide is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AI-061 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AI-061 in Solid Tumor Drug Details: AI-061 is under development for the treatment of advanced...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TolDCB-29 in Rheumatoid Arthritis
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TolDCB-29 in Rheumatoid Arthritis Drug Details: TolDCB-29 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Tozorakimab in Chronic Bronchitis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Tozorakimab in Chronic Bronchitis Drug Details: Tozorakimab (MEDI-3506) is under development for the treatment of diabetic kidney...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AMC-303 in Gastric Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.AMC-303 in Gastric Cancer Drug Details:AMC-303 is under development for the treatment of advanced and metastatic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Vaccine For Oncology in Thyroid Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Vaccine For Oncology in Thyroid Cancer Drug Details:Plasmodium immunotherapy is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Diphtheria + Haemophilus Influenzae [Serotype B] + Hepatitis B + Pertussis (Whole Cell) + Poliomyelitis + Tetanus) (Hexavalent) Vaccine in Hepatitis B
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.(Diphtheria + Haemophilus Influenzae [Serotype B] + Hepatitis B + Pertussis (Whole Cell) + Poliomyelitis +...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Gotistobart in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Gotistobart in Solid Tumor Drug Details: ONC-392 is under development for the treatment of metastatic...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.